» Articles » PMID: 18680545

Insulin-related Metabolism Following Hematopoietic Stem Cell Transplantation in Childhood

Overview
Publisher Wiley
Date 2008 Aug 6
PMID 18680545
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess insulin-related metabolism following hematopoietic stem cell transplantation (HSCT) in childhood.

Study Design: Thirty-four patients who underwent HSCT were compared with 21 patients with similar diseases who were not transplanted. Median follow-up was 3.6 yr after HSCT. Anthropometric parameters, fasting plasma glucose and insulin levels, hemoglobin A(1c) (HbA(1c)) and lipid profile were measured and compared.

Results: HbA(1c) was significantly higher (p = 0.001) in the study group. Two (5.8%) patients in the study group developed type 2 diabetes mellitus. Among thalassemic patients, significantly lower insulin resistance indices (p = 0.05) and fasting plasma insulin levels (p = 0.033) were found in the study group compared with the control group.

Conclusions: Attentive follow-up of insulin-related metabolism following HSCT in children is needed. The significance of the higher HbA1c values in the study group remains to be evaluated in a larger cohort of patients.

Citing Articles

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.

Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D Front Oncol. 2022; 12:963223.

PMID: 36276159 PMC: 9580018. DOI: 10.3389/fonc.2022.963223.


Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation.

Lu Y, Ma X, Pan J, Ma R, Jiang Y Lipids Health Dis. 2022; 21(1):65.

PMID: 35918766 PMC: 9344644. DOI: 10.1186/s12944-022-01665-3.


Novel Mutation Is Responsible for a Severe Form of Leucocyte Adhesion Deficiency Type 1.

Bouhouche A, Tabache Y, Askander O, Charoute H, Mesnaoui N, Belayachi L Biomed Res Int. 2022; 2022:1141280.

PMID: 35281597 PMC: 8913115. DOI: 10.1155/2022/1141280.


Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.

Wilhelmsson M, Vatanen A, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala U Bone Marrow Transplant. 2015; 50(6):850-7.

PMID: 25798676 DOI: 10.1038/bmt.2015.43.